Clinical trial
A Phase II Study of DMP 115 to Assess Focal Liver Lesions
NCT00162058 · Lantheus Medical Imaging, Industry · Completed
Key facts
| NCT number | NCT00162058 |
|---|---|
| Title | A Phase II Study of DMP 115 to Assess Focal Liver Lesions |
| Official title | An Open-Label, Non-Randomized, Phase II Trial To Assess Focal Liver Lesion Detection Using Definity-Enhanced Ultrasound Imaging |
| Lead sponsor | Lantheus Medical Imaging, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Liver Disease |
| Intervention type | Drug |
| Interventions | Peflutren Lipid Microsphere Injectable Suspension |
| Enrollment | 80 |
| Start date | Mar 1, 2004 |
| Primary completion | Apr 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Sep 13, 2005 |
| Last update posted | Aug 18, 2011 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: